Science for a better life

Latest News

For media enquiries please contact one of the following people:

Pharmaceuticals and Consumer Health: Michelle D'Heureux
Phone: +61 428 502 682

Crop Science and Animal Health: Lachlan Bird
Phone: +61 3 9248 6851

Bayer New Zealand: William Malpass
Phone: +64 9 441 8591

News

Friday - May 25, 2018

Bayer is making good progress strategically
Acquisition of Monsanto expected to be closed in the near future / 2017 sales and earnings at the prior-year level / Dividend to be raised for the eighth time in succession – to 2.80 euros per share / Start to fiscal 2018 overshadowed by currency effects More

Thursday - May 03, 2018

Bayer Q1 2018: Operational business held back by currency effects – Major progress with Monsanto acquisition
Group sales increase by 2.0 percent (Fx & portfolio adj.) to 9.138 billion euros / EBITDA before special items down year on year due to currency effects / Net income declines by 6.2 percent to 1.954 billion euros / Core earnings per share down 1.3 percent at 2.28 euros / European Commission and additional regulators conditionally approve Monsanto acquisition / Currency adjusted Group outlook for 2018 confirmed More

Wednesday - April 04, 2018

Combining tradition with modernity:
Bayer hones its brand profile More

Wednesday - March 21, 2018

European Commission conditionally approves Bayerâ€™s proposed acquisition of Monsanto
Closing of transaction planned for the second quarter of 2018 More

Wednesday - February 28, 2018

Transfers of Value to Healthcare Professionals
Bayer is a strong advocate of the pharmaceutical industryâ€™s ongoing efforts to increase transparency around its business. More

Wednesday - February 28, 2018

Bayer: business at prior-year level â€“ on track with strategy
Group sales increased by 1.5 percent (Fx & portfolio adj.) to 35.015 billion euros / Another record year for Pharmaceuticals / Weak business development at Consumer Health / Crop Science business down against prior year due to situation in Brazil â€“ measures taking effect / EBITDA before special items level year on year at 9.288 billion euros / Net income raised by 61.9 percent to 7.336 billion euros / Core earnings per share increased by 1.0 percent to 6.74 euros / Covestro deconsolidated â€“ additional cash inflows of 4.7 billion euros / Monsanto acquisition expected to close in second quarter of 2018 / Group outlook for 2018: increase in sales (Fx & portfolio adj.), EBITDA before special items and core earnings per share at prior-year level due to currency effects More

Wednesday - November 15, 2017

Heiko Schipper to join Bayer Board of Management and head Consumer Health Division
Erica Mann to leave Bayer effective March 31, 2018 More

Thursday - October 26, 2017

Bayer Q3 2017: Sales and earnings increased
Covestro deconsolidated / Group sales grow by 1.2 percent (Fx & portfolio adj.) to EUR 8,025 million / EBITDA before special items up by 4.1 percent to EUR 2,204 million / Net income of EUR 3,881 million including Covestro book profit More

Monday - October 16, 2017

Call for improved health literacy and self-care as new research finds up to seven million Australians are not actively managing their health
University of Canberra research, launched by the Federal Assistant Minister for Health, the Hon Dr David Gillespie MP, suggests pressing need for better online resources in health, food and nutrition for underserved communities More

Tuesday - September 12, 2017

Wolfgang Nickl to be new Chief Financial Officer at Bayer AG
Nickl will succeed Johannes Dietsch as the companyâ€™s Chief Financial Officer on June 1, 2018 More

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32